• Ticker:- PPH;false;MVPPH;
  • Ticker Group:- ETFEQ_IND;false;;
  • How to Purchase

Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

Pharmaceutical ETF PPH

  • Full Name: Market Vectors®
    Pharmaceutical ETF (PPH)

    Management Style: Replication

    Underlying Index: Market Vectors US Listed Pharmaceutical 25 Index (MVPPHTR)

    Index Provider: Market Vectors Index Solutions

    Index Description: MVPPHTR is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded pharmaceutical companies.

  •  
      

    • Fund Ticker

      PPH
    • Exchange

      NYSE Arca
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVPPHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 10/30/14

    • 30-Day SEC Yield1

      1.91%
    • Total Net Assets

      $384.7M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.43%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Quarterly
    • Next Distribution Date

      12/26/2014
  • Portfolio Composition (%)
    as of 10/30/14

    • % of Net Assets
    • Stocks

      100.09
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      -0.09
  • Download All HoldingsAll Holdings (%)as of 10/30/14

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Johnson & Johnson
    JNJ US
    400,492
    42,868,66411.14
    Novartis Ag
    NVS US
    410,195
    37,717,4329.80
    Pfizer Inc
    PFE US
    951,007
    28,378,0487.38
    Merck & Co Inc
    MRK US
    377,408
    21,629,2525.62
    Bristol-Myers Squibb Co
    BMY US
    336,966
    19,874,2545.17
    Novo Nordisk A/S
    NVO US
    416,208
    19,232,9725.00
    Abbvie Inc
    ABBV US
    300,965
    18,413,0384.79
    Glaxosmithkline Plc
    GSK US
    404,502
    18,259,2204.75
    Actavis Plc
    ACT US
    72,827
    17,712,2544.60
    Sanofi
    SNY US
    384,302
    17,562,6024.56
    Abbott Laboratories
    ABT US
    401,221
    17,449,1024.54
    Eli Lilly & Co
    LLY US
    257,197
    17,180,7604.47
    Astrazeneca Plc
    AZN US
    230,422
    16,728,6374.35
    Allergan Inc/United States
    AGN US
    86,766
    16,436,9514.27
    Teva Pharmaceutical Industries Ltd
    TEVA US
    260,267
    14,697,2773.82
    Mckesson Corp
    MCK US
    59,317
    12,069,8233.14
    Valeant Pharmaceuticals International I
    VRX US
    90,845
    11,947,0263.11
    Shire Plc
    SHPG US
    59,255
    11,816,6323.07
    Perrigo Co
    PRGO US
    35,144
    5,669,7821.47
    Mylan Inc/Pa
    MYL US
    104,297
    5,462,0341.42
    Zoetis Inc
    ZTS US
    133,245
    4,972,7041.29
    Mallinckrodt Plc
    MNK US
    30,597
    2,840,3200.74
    Endo Pharmaceuticals Holdings Inc
    ENDP US
    34,327
    2,275,5370.59
    Hospira Inc
    HSP US
    40,483
    2,195,7980.57
    Salix Pharmaceuticals Ltd
    SLXP US
    11,768
    1,700,4760.44
    Other/Cash
    -340,742-0.09
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.